BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Metis Pharmaceuticals

Metis Pharmaceuticals logo

Founded
2020
Geography
China based
Funding
$86 M

METiS Pharmaceuticals Inc is the world’s first AI-driven drug formulation company. Through the integration of machine learning, quantum simulation, and high-throughput experimentation, we enable formulation scientists to rapidly, comprehensively, and intelligently develop novel drug candidates.
Metis is founded by an enthusiastic team of MIT researchers and serial entrepreneurs. Our cross-disciplinary expertise and deep industry experiences allow Metis to innovate drug formulation and quickly bring differentiable drug products from benchtop to market.

Technologies

AI Companies (Drug Discovery)   Quantum Theory in Drug Discovery  

R&D Platform

METiS Pharmaceuticals is a venture-backed, preclinical biotech company. Our team of MIT researchers and serial entrepreneurs built the world's first AI-driven formulation platform to enable targeted, smart novel drug candidates. Through the integration of machine learning, quantum simulation, and high-throughput experimentation, we enable formulation scientists to rapidly, comprehensively and intelligently develop clinically differentiable products. These disruptive ways of working fundamentally transform drug development, and drug product lifecycle management, and ultimately bring more quality drug products to patients.


Pipelines

None
Preclinical  |  Visit website

Our breakthrough formulation platform technology enables us to develop targeted, smart novel drug candidates, and deliver risk-mitigated, faster-to-market drug products. We collaborate with XtalPi Inc, a leading computation-driven biotech company, to develop new formulation drug products to address unmet clinical needs.

Products

 

Services

No services posted yet